Larimar Therapeutics (LRMR)
(Delayed Data from NSDQ)
$7.74 USD
-0.49 (-5.90%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $7.99 +0.25 (3.23%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
03/13/2025
Time: -- |
12/2024 | $-0.31 | -0.98% |
Earnings Summary
For their last quarter, Larimar Therapeutics (LRMR) reported earnings of -$0.24 per share, beating the Zacks Consensus Estimate of $-0.37 per share. This reflects a positive earnings surprise of 35.14%. Look out for LRMR's next earnings release expected on March 13, 2025. For the next earning release, we expect the company to report earnings of -$0.31 per share, reflecting a year-over-year decrease of 3.33%.
Earnings History
Price & Consensus
Zacks News for LRMR
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
LRMR: What are Zacks experts saying now?
Zacks Private Portfolio Services